Home › NDC Lookup › RxCUI directory › RxCUI 2683291

24 HR deutetrabenazine 36 MG Extended Release Oral Tablet [Austedo] — RxCUI 2683291

RxNorm drug concept · Semantic branded drug
RxCUI 2683291 Semantic branded drug · SBD ● Current RxNorm concept 13 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2683291
Official name24 HR deutetrabenazine 36 MG Extended Release Oral Tablet [Austedo]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAustedo 36 MG 24 HR Extended Release Oral Tablet; Austedo XR 36 MG 24HR Extended Release Oral Tablet
FDA products mapped13
Package NDCs mapped14
Reported Medicaid activity (SDUD)59,566 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Deutetrabenazine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It helps control the involuntary, uncontrolled movements that come with Huntington's disease (called chorea) or that develop after long-term use of certain psychiatric medications...
  • What exactly does deutetrabenazine do — why did my doctor prescribe it?
  • Yes, and it's different for each one. Austedo XR (the once-daily extended-release tablet) can be taken with or without food — food doesn't affect how much of the drug gets into you...
  • Does it matter whether I take Austedo XR or Austedo with food?
📖 Read our full Deutetrabenazine guide →

🕸️ Concept Web — How 24 HR deutetrabenazine 36 MG Extended Release Or... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR deutetrabenazine 36 MG Extended Release Oral Tablet [Austedo] RxCUI 2683291

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Deutetrabenazine 1876905
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Austedo 1876911
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Deutetrabenazine Extended Release Oral Tablet 2630143
    • Deutetrabenazine Oral Product 1876907
    • Deutetrabenazine Pill 1876908
    • Deutetrabenazine Extended Release Oral Tablet [Austedo] 2630146
    • Austedo Oral Product 1876914
    • Austedo Pill 1876915
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Deutetrabenazine 36 MG [Austedo] SBDC · 2683290
  • Deutetrabenazine Extended Release Oral Tablet [Austedo] SBDF · 2630146
  • Austedo Oral Product SBDG · 1876914
  • Austedo Pill SBDG · 1876915
  • Austedo BN · 1876911

📦 FDA Products & Package NDCs

13 products · 14 package NDCs
14 package NDCs map to RxCUI 2683291 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68546-0170-60 60 TABLET, COATED in 1 BOTTLE (68546-170-60) Austedo Teva Neuroscience, Inc. 2017-04-12
68546-0171-60 60 TABLET, COATED in 1 BOTTLE (68546-171-60) Austedo Teva Neuroscience, Inc. 2017-04-12
68546-0172-60 60 TABLET, COATED in 1 BOTTLE (68546-172-60) Austedo Teva Neuroscience, Inc. 2017-04-12
68546-0176-28 1 BLISTER PACK in 1 CARTON (68546-176-28) / 1 KIT in 1 BLIS... AUSTEDO Teva Neuroscience, Inc. 2020-02-01
68546-0470-56 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68546-... AUSTEDO XR Teva Neuroscience, Inc. 2023-02-21
68546-0471-56 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68546-... AUSTEDO XR Teva Neuroscience, Inc. 2023-02-21
68546-0472-56 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68546-... AUSTEDO XR Teva Neuroscience, Inc. 2023-02-21
68546-0473-56 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68546-... AUSTEDO XR Teva Neuroscience, Inc. 2024-05-29
68546-0474-56 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68546-... AUSTEDO XR Teva Neuroscience, Inc. 2024-05-29
68546-0475-56 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68546-... AUSTEDO XR Teva Neuroscience, Inc. 2024-05-29
68546-0476-56 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68546-... AUSTEDO XR Teva Neuroscience, Inc. 2024-05-29
68546-0477-28 1 KIT in 1 BLISTER PACK (68546-477-28) * 7 TABLET, FILM CO... AUSTEDO XR Teva Neuroscience, Inc. 2024-07-01
68546-0477-29 1 BLISTER PACK in 1 CARTON (68546-477-29) / 1 KIT in 1 BLIS... AUSTEDO XR Teva Neuroscience, Inc. 2024-07-01
68546-0479-56 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68546-... AUSTEDO XR Teva Neuroscience, Inc. 2024-07-01
Observed labelers: Teva Neuroscience, Inc. (14) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.